[Multiplicity and significance of autoantibodies in the megaloblastic anemias].

R. Herbeuval,J. Duheille,J. Nicolas,R. Wolff

1968-11-02

Abstract:

What problem does this paper attempt to address?

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update

DeLisa Fairweather,Danielle J. Beetler,Nicolas Musigk,Bettina Heidecker,Melissa A. Lyle,Leslie T. Cooper,Katelyn A. Bruno

DOI: https://doi.org/10.3389/fcvm.2023.1129348

IF: 3.6

2023-03-03

Frontiers in Cardiovascular Medicine

Abstract:In the past decade there has been a growing interest in understanding sex and gender differences in myocarditis and dilated cardiomyopathy (DCM), and the purpose of this review is to provide an update on this topic including epidemiology, pathogenesis and clinical presentation, diagnosis and management. Recently, many clinical studies have been conducted examining sex differences in myocarditis. Studies consistently report that myocarditis occurs more often in men than women with a sex ratio ranging from 1:2–4 female to male. Studies reveal that DCM also has a sex ratio of around 1:3 women to men and this is also true for familial/genetic forms of DCM. Animal models have demonstrated that DCM develops after myocarditis in susceptible mouse strains and evidence exists for this progress clinically as well. A consistent finding is that myocarditis occurs primarily in men under 50 years of age, but in women after age 50 or post-menopause. In contrast, DCM typically occurs after age 50, although the age that post-myocarditis DCM occurs has not been investigated. In a small study, more men with myocarditis presented with symptoms of chest pain while women presented with dyspnea. Men with myocarditis have been found to have higher levels of heart failure biomarkers soluble ST2, creatine kinase, myoglobin and T helper 17-associated cytokines while women develop a better regulatory immune response. Studies of the pathogenesis of disease have found that Toll-like receptor (TLR)2 and TLR4 signaling pathways play a central role in increasing inflammation during myocarditis and in promoting remodeling and fibrosis that leads to DCM, and all of these pathways are elevated in males. Management of myocarditis follows heart failure guidelines and there are currently no disease-specific therapies. Research on standard heart failure medications reveal important sex differences. Overall, many advances in our understanding of the effect of biologic sex on myocarditis and DCM have occurred over the past decade, but many gaps in our understanding remain. A better understanding of sex and gender effects are needed to develop disease-targeted and individualized medicine approaches in the future.

cardiac & cardiovascular systems
Sex-based differences in the phenotypic expression and prognosis of idiopathic non-ischaemic cardiomyopathy: a cardiovascular magnetic resonance study

Maggie Mallabone,Dina Labib,Ahmed Abdelhaleem,Steven Dykstra,Richard B Thompson,D Ian Paterson,Sam K Thompson,Fereshteh Hasanzadeh,Yoko Mikami,Sandra Rivest,Jacqueline Flewitt,Yuanchao Feng,Matthew Macdonald,Melanie King,Michael Bristow,Louis Kolman,Andrew G Howarth,Carmen P Lydell,Robert Jh Miller,Nowell M Fine,James A White,Robert J H Miller

DOI: https://doi.org/10.1093/ehjci/jeae014

2024-01-17

European Heart Journal - Cardiovascular Imaging

Abstract:Abstract Aims We sought to characterize sex-related differences in cardiovascular magnetic resonance-based cardiovascular phenotypes and prognosis in patients with idiopathic non-ischaemic cardiomyopathy (NICM). Methods and results Patients with NICM enrolled in the Cardiovascular Imaging Registry of Calgary (CIROC) between 2015 and 2021 were identified. Z-score values for chamber volumes and function were calculated as standard deviation from mean values of 157 sex-matched healthy volunteers, ensuring reported differences were independent of known sex-dependencies. Patients were followed for the composite outcome of all-cause mortality, heart failure admission, or ventricular arrhythmia. A total of 747 patients were studied, 531 (71%) males. By Z-score values, females showed significantly higher left ventricular (LV) ejection fraction (EF; median difference 1 SD) and right ventricular (RV) EF (difference 0.6 SD) with greater LV mass (difference 2.1 SD; P < 0.01 for all) vs. males despite similar chamber volumes. Females had a significantly lower prevalence of mid-wall striae (MWS) fibrosis (22% vs. 34%; P < 0.001). Over a median follow-up of 4.7 years, 173 patients (23%) developed the composite outcome, with equal distribution in males and females. LV EF and MWS were significant independent predictors of the outcome (respective HR [95% CI] 0.97 [0.95–0.99] and 1.6 [1.2–2.3]; P = 0.003 and 0.005). There was no association of sex with the outcome. Conclusion In a large contemporary cohort, NICM was uniquely expressed in females vs. males. Despite similar chamber dilation, females demonstrated greater concentric remodelling, lower reductions in bi-ventricular function, and a lower burden of replacement fibrosis. Overall, their prognosis remained similar to male patients with NICM.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Predicting Major League Baseball Championship Winners through Data Mining

B. Tolbert,T. Trafalis

DOI: https://doi.org/10.30958/AJSPO.3.4.1

2016-11-30

Abstract:The world of sports is highly unpredictable. Fans of any sport are interested in predicting the outcomes of sporting events. Whether it is prediction based off of experience, a gut feeling, instinct, simulation based off of video games, or simple statistical measures, many fans develop their own approach to predicting the results of games. In many situations, these methods are not reliable and lack a fundamental basis. Even the experts are unsuccessful in most situations. In this paper we present a sports data mining approach to uncover hidden knowledge within the game of baseball. The goal is to develop a model using data mining methods that will predict American League champions, National League champions, and World Series winners at a higher success rate compared to traditional models. Our approach will analyze historical regular season data of playoff contenders by applying kernel machine learning schemes in an effort to uncover potentially useful information that helps predict future champions.
Abstract TMP65: Sex Differences in Outcomes of Acute Myocardial Injury After Stroke

Michela Rosso,Helena Stengl,Ramanan Ganeshan,Simon Hellwig,Markus G Klammer,Regina von Rennenberg,Sophie Böhme,Heinrich J Audebert,Christian H Nolte,Matthias Endres,Scott E Kasner,Jan F Scheitz

DOI: https://doi.org/10.1161/str.55.suppl_1.tmp65

IF: 10.17

2024-02-01

Stroke

Abstract:Introduction: Sex differences in presentation, treatment, and prognosis of cardiovascular disorders are well recognized. Although an association between acute myocardial injury and mortality after ischemic stroke has been demonstrated, it is unclear whether prevalence and outcome of post-stroke acute myocardial injury differ between women and men. Methods: We prospectively screened consecutive patients with acute ischemic stroke and serial high-sensitivity cardiac troponin T (hs-cTnT) measurements admitted to our center (January 2019-December 2020). Acute myocardial injury was defined as at least one hs-cTnT value above the upper reference limit (URL=14 ng/L) with a rise/fall of >20%. Additionally, rates of acute myocardial injury were calculated with sex-specific hs-cTnT cut-offs (women URL=9ng/L; men URL=16ng/L). Results: Of 1,067 patients included, 494 were women (46%). Women were older, had higher rate of known atrial fibrillation, were more likely to be functional dependent before admission, and had higher stroke severity (all p-values <0.05). The prevalence of acute myocardial injury differed by sex (29% women vs 23% men, P =0.024). In multivariate analysis, statistically significant associations between acute myocardial injury and outcomes were observed in women (7-day mortality: aOR=3.2 [1.07-9.3]; in-hospital mortality: aOR=3.3 [1.4-7.6]; mRS at discharge: aOR=1.6 [1.1-2.4]), but not in men (Fig.1). The implementation of sex-specific cut-offs did not increase the prognostic value of acute myocardial injury for unfavorable outcomes. The ROC-derived optimal cut-offs of hs-cTnT peak values for predicting of early mortality was higher than current URLs and sex-specific (women=29.5 ng/L vs men=66 ng/L; negative predictive value: 98.46% and 99.23%) (Fig.2). Conclusions: The prevalence of acute myocardial injury after ischemic stroke and its association with mortality and unfavorable functional outcome might be sex-dependent.

peripheral vascular disease,clinical neurology
Sex-related Differences in Patients with Infective Endocarditis Requiring Cardiac Surgery: Insights from the CAMPAIGN Study Group

Paula Ackermann,Mateo Marin-Cuartas,Carolyn Weber,Manuela De La Cuesta,Artur Lichtenberg,Asen Petrov,Christian Hagl,Hug Aubin,Klaus Matschke,Mahmoud Diab,Maximilian Luehr,Payam Akhyari,Sems-Malte Tugtekin,Shekhar Saha,Torsten Doenst,Thorsten Wahlers,Michael A Borger,Martin Misfeld

DOI: https://doi.org/10.1093/ejcts/ezae292

IF: 4.534

2024-07-29

European Journal of Cardio-Thoracic Surgery

Abstract:Abstract OBJECTIVES Sex-related differences play a role in cardiovascular disease-related outcomes. There is, however, a knowledge gap regarding sex-specific differences in patients with infective endocarditis (IE) requiring surgical treatment. This study aims to analyze sex-related differences in the clinical presentation, treatment, and clinical outcomes of patients with IE requiring surgical treatment from the multicentric Germany-wide CAMPAIGN registry. METHODS Patients with IE who underwent cardiac surgery between 1994 and 2018 at six German centers were retrospectively analyzed. Outcomes were compared based on patients' sex. Primary outcomes were 30-day mortality and mid-term survival. RESULTS A total of 4917 patients were included in the analysis (1364 female [27.7%] and 3553 male [72.3%]). Female patients presented with more comorbidities and higher surgical risk (EuroScore II 12.0% vs 10.0%, p < 0.001). The early postoperative course of female patients was characterized by longer ventilation times (20.0 hours vs 16.0 hours; p = 0.004), longer intensive care unit stay (4.0 days vs 3.0 days; p < 0.001), and more frequent new-onset dialysis (265 [20.3%]vs 549 [16.3%]; p = 0.001). The 30-day mortality was 13.8% and 15.5% in female and male patients, respectively (p = 0.06). The estimated mid-term survival was significantly higher amongst male patients (56.1% vs 45.4%; Log-rank p < 0.001). Female sex was an independent predictor of mid-term mortality (HR 1.2 [95% CI 1.0–1.4], p = 0.01). CONCLUSIONS Male patients more frequently undergo cardiac surgery for IE. However, female patients have a higher surgical risk profile and subsequently an increased early postoperative morbidity, but with similar 30-day mortality compared to male patients. The estimated mid-term survival is lower amongst female patients.

surgery,cardiac & cardiovascular systems,respiratory system
Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE‐MI echocardiographic substudy

Xiaowen Wang,Maria A. Pabon,Maja Cikes,Karola Jering,Wilfried Mullens,Lars Kober,Pardeep S. Jhund,Attila Kovacs,Bela Merkely,Yinong Zhou,John J.V. McMurray,Amil M. Shah,Sheila M. Hegde,Brian Claggett,Marc A. Pfeffer,Scott D. Solomon

DOI: https://doi.org/10.1002/ejhf.3472

2024-09-25

European Journal of Heart Failure

Abstract:Sex differences in the PARADISE‐MI echocardiographic substudy. Aims The incidence of heart failure hospitalization is higher in women than in men after myocardial infarction (MI). Sex‐related differences in left ventricular (LV) remodelling may contribute to the differences in post‐MI outcomes. The aim of this study was to assess sex differences in echocardiographic parameters post‐MI, and whether the relationship between echocardiographic parameters and clinical outcomes differs by sex. Methods and results In the PARADISE‐MI trial, patients were randomized to sacubitril/valsartan or ramipril within 0.5 to 7 days of high‐risk MI. In the pre‐specified echocardiographic substudy, 544 patients underwent echocardiography at the time of randomization and after 8 months. We compared key echocardiographic parameters in men and women and their association with primary composite outcome (cardiovascular death or incident heart failure). At baseline, women had higher LV ejection fraction (LVEF), lower LV end‐diastolic volume (LVEDV) index, LV end‐systolic volume (LVESV) index, and LV mass index. After adjusting for baseline clinical differences, changes in these echocardiographic parameters from baseline to 8 months were not significantly different in women versus men. Lower LVEF, higher LVEDV, LVESV, left atrial volume index, and average E/e' were associated with a higher risk of the primary composite outcome. Sex did not modify the relationship between echocardiographic parameters and clinical outcome. Conclusions Despite baseline differences in measures of cardiac function between men and women following acute high‐risk MI, there were no significant sex‐related changes in chamber size or LV function. Sex did not modify the association between echocardiographic parameters and clinical outcome.

cardiac & cardiovascular systems
Sex differences in outcomes of patients with cardiogenic shock due to acute myocardial infarction: a systematic review and epidemiological meta-analysis

N Hill,T Fisher,A Kalakoutas,A Warren,A G Proudfoot,K S Rathod,A Lahlou

DOI: https://doi.org/10.1093/eurheartj/ehae666.1749

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Women are at higher risk of mortality from ST-elevation myocardial infarction (1) when compared to men. There is a lack of consensus among studies examining the effect of sex on outcomes from cardiogenic shock due to acute myocardial infarction (AMI-CS) (2-5). In this systematic review and meta-analysis, we sought to assess the relationship between outcomes of AMI-CS and sex. Purpose To examine sex-related differences in mortality in patients with cardiogenic shock secondary to acute myocardial infarction (AMI-CS). Methods Cochrane Central, PubMed, MEDLINE and EMBASE were searched in February 2023 for studies reporting in-hospital or 30-day sex-specific mortality in patients with cardiogenic shock. Inclusion criteria consisted of observational or randomised controlled trials of adult patients with cardiogenic shock that reported unadjusted or adjusted (by odds or risk ratio) mortality rates by sex. In-hospital or 30-day mortality were treated as equivalent. Data were extracted for study size, number of men and women, unadjusted and adjusted mortality rates, and factors used in multivariable analysis. Studies were assessed for risk of bias and publication bias. Meta-analysis was performed using DerSimonian-Laird random effects model with inverse variant weighting, due to predicted high heterogeneity of included studies. Data are reported as odds ratios (ORs) with 95% confidence interval (CI). P values were adjusted for multiple comparison using Holm-Bonferonni correction. The primary outcomes were unadjusted and adjusted sex-specific mortality rates due to AMI-cardiogenic shock. Results 4,286 studies were identified and 37 met inclusion criteria, pooling a total of 630,890 patients. Raw 30-day/in-hospital mortality of females with AMI-cardiogenic shock was 41.2% compared to 32.3% in males. Unadjusted OR for mortality in females was 1.42 (95% CI 1.31–1.55, p <0.001, t2 = 0.02, I2 = 70.3%), and the adjusted OR was 1.11 (95% CI 1.04–1.20, p <0.001, t2 = 0.01, I2 = 76.8%). Eight studies included data on use of mechanical circulatory support (MCS), which was used in 31.2% of females compared to 39.9% of males. OR for use of MCS in females compared to males was 0.71 (95% CI 0.66–0.77, p < 0.001, t2 = 0.003, I2 = 35.2%). Conclusions Women with AMI-related cardiogenic shock are at greater risk of death compared to male patients and are less often treated with MCS. Potential explanations include residual confounding factors, differences in AMI-cardiogenic shock pathophysiology between men and women, and sex-related differences in healthcare behaviours, but we cannot exclude the effect of systemic bias on outcomes. Further research is required to address the causes of sex disparities in outcomes and ensure equitable management of AMI-cardiogenic shock in women.Unadjusted sex outcomes from AMI-CSAdjusted sex outcomes from AMI-CS

cardiac & cardiovascular systems
Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study

Ran Cheng,Chuan Liu,Jie Yang,Yuanqi Yang,Renzheng Chen,Xiaohan Ding,Xubin Gao,Jingbin Ke,Fangzhengyuan Yuan,Chunyan He,Yang Shen,Limin Zhang,Ping Li,Hu Tan,Lan Huang

DOI: https://doi.org/10.3389/fphys.2021.632123

IF: 4

2021-02-16

Frontiers in Physiology

Abstract:Male novel coronavirus disease (COVID-19) patients tend to have poorer clinical outcomes than female patients, while the myocardial injury is strongly associated with COVID-19-related adverse events. Owing to a lack of corresponding data, we aimed to investigate the sex differences in the incidence of myocardial injury in COVID-19 patients and to identify the potential underlying mechanisms, which may partly account for the sex bias in the incidence of adverse events. This retrospective study included 1,157 COVID-19 patients who were hospitalized in Huoshenshan Hospital from 12 March 2020 to 11 April 2020. Data on the patients’ demographic characteristics, initial symptoms, comorbidities and laboratory tests were collected. Totally, 571 (49.4%) female and 586 (50.6%) male COVID-19 patients were enrolled. The incidence of myocardial injury was higher among men than women (9.2 vs. 4.9%, p = 0.004). In the logistic regression analysis, age, and chronic kidney disease were associated with myocardial injury in both sexes. However, hypertension [odds ratio (OR) = 2.25, 95% confidence interval (CI) 1.20–4.22], coronary artery disease ( OR = 2.46, 95% CI 1.14–5.34), leucocyte counts ( OR = 3.13, 95% CI 1.24–7.86), hs-CRP ( OR = 4.45, 95% CI 1.33–14.83), and D-dimer [ OR = 3.93 (1.27–12.19), 95% CI 1.27–12.19] were independent risk factors only in the men. The correlations of hs-CRP and D-dimer with hs-cTnI and BNP were stronger in the men. The incidence of myocardial injury in COVID-19 patients is sex-dependent, predominantly in association with a greater degree of inflammation and coagulation disorders in men. Our findings can be used to improve the quality of clinical management in such settings.

physiology
Sex differences in acute myocardial infarction - Preliminary results from an umbrella review

C Torres,A K B Ann Kristin Bjornnes,M H Milada Hagen,S H Sigrun Halvorsen,T J Tomas Jernberg,I L Irene Lie

DOI: https://doi.org/10.1093/eurjcn/zvae098.029

2024-07-01

European Journal of Cardiovascular Nursing

Abstract:Abstract Background Cardiovascular disease (CVD) is the leading cause of premature death among women, and the negative impact on public health is profound. Women have higher rates of comorbidities, complications such as stroke, in addition to higher mortality compared to men (1-6) and targeting sex-related differences regarding the treatment of CVD in women is of great importance to prevent the number of CVD events. The purpose of this study was to get an overview of the systematic reviews and meta-analyses investigating sex differences in patients with acute myocardial infarction (AMI) the past 10 years. Methods A systematic search was carried out in Epistemonikos, the largest database of systematic reviews that screens PubMed, Cochrane, Embase, CINAHL, PsycInfo and others (i.e., currently nine databases) (7, 8). The search was conducted 12 January 2024, with the general search strings: (1) sex differences OR gender differences AND myocardial infarction, (2) sex differences OR gender differences OR women OR female AND myocardial infarction. The search was restricted to systematic reviews conducted the last 10 years. Results Forty-nine (search 1: 19, search 2: 30) systematic reviews and meta-analyses were identified, and five studies investigating sex differences in relation to AMI were included. Two systematic reviews, Babioakis (2021) and Meer (2015), reported of longer door-to-balloon (D2B) time and/or symptom-to-balloon (S2B) time in female patients presenting with STEMI and referred for PCI, compared to male patients (9). Chaudhary (2022) investigated adverse event of MINOCA (more commonly in women/ younger age (51-59 years) and reported higher risk of MACE among women than men (10.1% vs. 9.1%, OR 1.15, 1.04-1.23), in addition to higher incidence of stroke (3.5% vs. 2.2%, OR 1.3, 1.01-1.68), however no significantly differences were observed for all-cause mortality, non-fatal AMI, and cardiovascular readmissions between the groups (10). Three systematic reviews reported of higher risk of mortality after STEMI among women, compared to men (11-13). Xi (2022) reported of higher risk of short-term mortality (RR, 1.73; 95% CI 1.53 to 1.96)) (adjusted RR, 1.24; 95% CI 1.11 to 1.38) (13), Pancholy (2014) reported of higher risk of in-hospital mortality (RR, 1.93; 95% CI, 1.75-2.14) (adjusted RR, 1.48; 95% CI, 1.07-2.05) (11), and van der Meer (2015) reported of higher crude short- and long-term mortality in women, in addition to less use of GP IIb/IIIa inhibitors in women, compared to men (women 51%, men 57%) (12). Conclusions Our umbrella review revealed that women had longer timeline for treatment in AMI, had less use of medication and higher risk of mortality and MACE compared to men. Clinical practice needs further improvements in management in female patients.

nursing,cardiac & cardiovascular systems
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative

Hannah Lu,Laura A. Hatfield,Saeed Al-Azazi,Pieter Bakx,Amitava Banerjee,Nitzan Burrack,Yu-Chin Chen,Christina Fu,Michal Gordon,Renaud Heine,Nicole Huang,Dennis T. Ko,Lisa M. Lix,Victor Novack,Laura Pasea,Feng Qiu,Therese A. Stukel,Carin A. Uyl-de Groot,Gabe Weinreb,Bruce E. Landon,Peter Cram

DOI: https://doi.org/10.1161/circoutcomes.123.010144

2024-02-10

Circulation Cardiovascular Quality and Outcomes

Abstract:Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Sex differences in acute myocardial infarction treatment and outcomes are well documented, but it is unclear whether differences are consistent across countries. The objective of this study was to investigate the epidemiology, use of interventional procedures, and outcomes for older females and males hospitalized with ST-segment–elevation myocardial infarction (STEMI) and non–ST-segment–elevation myocardial infarction (NSTEMI) in 6 diverse countries.METHODS:We conducted a serial cross-sectional cohort study of 1 508 205 adults aged ≥66 years hospitalized with STEMI and NSTEMI between 2011 and 2018 in the United States, Canada, England, the Netherlands, Taiwan, and Israel using administrative data. We compared females and males within each country with respect to age-standardized hospitalization rates, rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery within 90 days of hospitalization, and 30-day age- and comorbidity-adjusted mortality.RESULTS:Hospitalization rates for STEMI and NSTEMI decreased between 2011 and 2018 in all countries, although the hospitalization rate ratio (rate in males/rate in females) increased in virtually all countries (eg, US STEMI ratio, 1.58:1 in 2011 and 1.73:1 in 2018; Israel NSTEMI ratio, 1.71:1 in 2011 and 2.11:1 in 2018). Rates of cardiac catheterization, percutaneous coronary intervention, and coronary artery bypass graft surgery were lower for females than males for STEMI in all countries and years (eg, US cardiac catheterization in 2018, 88.6% for females versus 91.5% for males; Israel percutaneous coronary intervention in 2018, 76.7% for females versus 84.8% for males) with similar findings for NSTEMI. Adjusted mortality for STEMI in 2018 was higher for females than males in 5 countries (the United States, Canada, the Netherlands, Israel, and Taiwan) but lower for females than males in 5 countries for NSTEMI.CONCLUSIONS:We observed a larger decline in acute myocardial infarction hospitalizations for females than males between 2011 and 2018. Females were less likely to receive cardiac interventions and had higher mortality after STEMI. Sex disparities seem to transcend borders, raising questions about the underlying causes and remedies.

cardiac & cardiovascular systems
Prospective comparison of temporal myocardial function in men vs women after anterior ST-elevation myocardial infarction

S Jha,A Shekka Espinosa,L Molander,A Poller,V Sevastianova,K Simons,T Gudmundsson,E Bobbio,R Zeijlon,P Thorild,A Andersson,S Salahuddin,K Skoglund,E Omerovic,B Redfors

DOI: https://doi.org/10.1093/eurheartj/ehae666.1683

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Compared to men, women have been reported to have increased morbidity and mortality after ST-elevation myocardial infarction (STEMI), but sex differences in cardiac function in the acute and subacute phases of STEMI are incompletely understood. Objective To prospectively compare changes in cardiac function over the acute and subacute phases after anterior STEMI with timely reperfusion in women versus men. Methods The Stunning in Takotsubo versus Acute Myocardial Infarction (STAMI) study prospectively enrolled 94 men and 36 women with anterior STEMI. Echocardiography and blood sampling were performed within 4 hours of admission and at 1, 2, 3, 7, 14 and 30 days after admission. The primary outcome was akinesia recovery, defined as the difference in the per cent akinesia observed at baseline versus follow-up. Secondary outcomes included wall motion score index (WMSI), left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS). Mixed effects linear regression or zero-inflated tobit models with random intercepts were used to model echocardiographic parameters over time. Results Baseline patient characteristics were similar in both groups. The difference between women and men in akinesia recovery at 30 days was 8.4% (95% confidence interval [CI] 1.23-14.99). The covariate-adjusted Bayesian posterior probability that akinesia recovery and WMSI improvement at 30 days are more significant in women than men were 95% and 99%, respectively. Similar but less pronounced trends towards greater improvement in women than men were observed for LVEF and GLS. Conclusions After anterior STEMI with timely reperfusion, cardiac dysfunction recovered to a greater extent in women than in men.

cardiac & cardiovascular systems
Specificities of Myocardial Infarction and Heart Failure in Women

Milica Dekleva,Ana Djordjevic,Stefan Zivkovic,Jelena Suzic Lazic

DOI: https://doi.org/10.3390/jcm13237319

IF: 3.9

2024-12-03

Journal of Clinical Medicine

Abstract:Substantial evidence from previous clinical studies, randomized trials, and patient registries confirms the existence of significant differences in cardiac morphology, pathophysiology, prevalence of specific coronary artery disease (CAD), and clinical course of myocardial infarction (MI) between men and women. The aim of this review is to investigate the impact of sex or gender on the development and clinical course of MI, the mechanisms and features of left ventricular (LV) remodeling, and heart failure (HF). The main sex-related difference in post-MI LV remodeling is adverse LV dilatation in males versus concentric LV remodeling or concentric LV hypertrophy in females. In addition, women have a higher incidence of microvascular dysfunction, which manifests as impaired coronary flow reserve, distal embolism, and a higher prevalence of the no-reflow phenomenon. Consequently, impaired myocardial perfusion after MI is more common in women than in men. Regardless of age or other comorbidities, the incidence of reinfarction, hospitalization for HF, and mortality is significantly higher in females. There is therefore a "sex paradox": despite the lower prevalence of obstructive CAD and HF with reduced ejection fraction (HFrEF), women have a higher mortality rate after MI. Different characteristics of the coronary network, such as plaque formation, microvascular dysfunction, and endothelial inflammation, as well as the prolonged time to optimal coronary flow restoration, secondary mitral regurgitation, and pulmonary vascular dysfunction, lead to a worse outcome in females. A better understanding of the mechanisms responsible for MI occurrence, LV remodeling, and HF in men and women would contribute to optimized patient therapy that would benefit both sexes.

medicine, general & internal
Post-COVID-19 illness and associations with sex and gender

Kenneth Mangion,Andrew J Morrow,Robert Sykes,Anna Kamdar,Catherine Bagot,George Bruce,Paul Connelly,Christian Delles,Vivienne B Gibson,Lynsey Gillespie,Pauline Hall Barrientos,Vera Lennie,Giles Roditi,Naveed Sattar,David Stobo,Sarah Allwood-Spiers,Alex McConnachie,Colin Berry,CISCO-19 investigators,Kevin G Blyth,Michael Briscoe,Colin Church,Stephen Dobbin,Keith Gillis,Antonia Ho,David J Lowe,Kaitlin J Mayne,Patrick B Mark,Christopher McGinley,Connor McKee,Oliver Peck,Alastair J Rankin,Claire Rooney,Sarah A Spiers,Ryan Wereski,Sylvia Wright,Lynn Abel,Douglas Grieve,Hannah Bayes,Jaclyn Carberry,Daniel Doherty,Ian Ferguson,Fraser Goldie,Laura Knox,Katherine Scot,Varun Sharma,Ammani Brown,Andrew Dougherty,Kirsty Fallon,Lesley Gilmour,Chloe Cowan,Sharon Kean,Jurgen Van-Melckebeke,Kim Moran-Jones,Debra Stuart,Maureen Travers,Tracey Hopkins,Laura Dymock,Evonne McLennan,Rosemary Woodward,Fiona Savage,Nicola Tynan,Sau Lee Chang,Mhairi Dupre,Lindsey Norton,Liam Peng,Clare Orange,Rory Gunson,Rosario Gonzalez-Lopez,Rebecca Stace,Elaine Butler,Jennifer S Lees,Rhian M Touyz,Paul Welsh,Massimo Palmarini,John G F Cleland,Bernard Kelly,Alasdair McIntosh,Dionne Russell,Sarah Weeden,Peter W Macfarlane,Louise Inglis,Jean Watt,Kathryn McLaren,Shahid Latif,Nick Hill,Dirk Husmeier,Xiaoyu Luo,Peter Kellman,Hui Xue,Amy Collinsworth,Sarah Mullen,Campbell Rogers,Heerajnarain Bulluck,David Carrick,David Corcoran,Iain Findlay,Ninian N Lang,Ross McGeoch,Sabrina Nordin,Alexander Payne,Keith Robertson,Nicola Ryan,Gruschen Veldtman,Robin P Weir,Stuart Watkins,Neil Basu,Iain McInnes,Stefan Siebert

DOI: https://doi.org/10.1186/s12872-023-03412-7

2023-08-08

Abstract:Background: Post-COVID-19 syndromes have associated with female sex, but the pathophysiological basis is uncertain. Aim: There are sex differences in myocardial inflammation identified using cardiac magnetic resonance (CMR) in post-COVID-19 patients, and in patient reported health outcomes following COVID-19 infection. Design: This prospective study investigated the time-course of multiorgan injury in survivors of COVID-19 during convalescence. Methods: Clinical information, blood biomarkers, and patient reported outcome measures were prospectively acquired at enrolment (visit 1) and 28-60 days post-discharge (visit 2). Chest computed tomography (CT) and CMR were performed at visit 2. Follow-up was carried out for serious adverse events, including death and rehospitalization. Results: Sixty-nine (43%) of 159 patients recruited were female. During the index admission, females had a lower peak C-reactive protein (74 mg/l (21,163) versus 123 mg/l (70, 192) p = 0.008) and peak ferritin (229 μg/l (103, 551) versus 514 μg/l (228, 1122) p < 0.001). Using the Modified Lake-Louise criteria, females were more likely to have definite evidence of myocardial inflammation (54% (37/68) versus 33% (30/90) p = 0.003). At enrolment and 28-60 days post-discharge, enhanced illness perception, higher levels of anxiety and depression and lower predicted maximal oxygen utilization occurred more commonly in women. The mean (SD, range) duration of follow-up after hospital discharge was 450 (88) days (range 290, 627 days). Compared to men, women had lower rates of cardiovascular hospitalization (0% versus 8% (7/90); p = 0.018). Conclusions: Women demonstrated worse patient reported outcome measures at index admission and 28-60 days follow-up though cardiovascular hospitalization was lower.
Comparison of clinical symptoms and prognosis of non-post-menopausal women to age matched men admitted with ST-elevation myocardial infarctions

J Schmucker,A Fach,R Osteresch,S Ruehle,R Hambrecht,H Wienbergen

DOI: https://doi.org/10.1093/eurheartj/ehae666.1678

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background Although ST-elevation-myocardial infarctions (STEMI) in women before menopause are relatively uncommon, previous studies have shown that women in general are more likely to present with atypical symptoms and to show higher adverse event rates, which might at least be attributable to the on average higher age of women during the index event. Aim of the present study was therefore to compare in an age-matched cohort of STEMI-patients younger 55 years the likelihood of atypical symptoms between genders and to investigate the impact of female gender on short and long-term-outcome. Methods Patients <55 years of age with STEMI admitted between 2006 and 2022 to a German heart center were included in the analysis and women were compared to men with regard to clinical symptoms and outcome. To exclude local bias women of all ages with STEMI from the registry were compared to men in a control group. Results Of 12094 STEMI-patients in the total cohort 3343 (28%) were women and 8751 (72%) were men. Women had a mean age of 69.7±13 yrs. compared to 62.2±12 in men. Women with STEMI had a 40% higher chance to present without typical chest pain (no CP, 12.0% vs. 8.5%, p<0.01) and were more likely to present with dyspnea (26.1% vs. 22.7% p<0.01). While rates of late STEMI-presenters were numerically higher in women, this difference failed to reach significance (12.8% vs. 11.9%, p=0.16). When focusing however on the study group (<55 yrs. of age) there was no more age difference (women 47.2±6 yrs. vs. 47.5±6 yrs. in men, p<0.3) and rates of no CP were not different between genders: 5.7%(women) vs. 5.4% (men), p=0.79, nor were rates of dyspnea : 20.0% (women) vs. 18.5% (men), p=0.45. There was even a trend towards lower rates of late STEMI-presenters in women: 8.3% vs. 10.9% in men, p=0.077, although diabetes-rates were higher in women (16.9% vs. 11.8%, p<0.01). Despite similar initial symptom presentations, women showed a marked 60% increase in 30-day- (6.9% vs. 4.3%, p=0.017) and 1-year-mortality (8.7% vs. 5.3%, p<0.01). The disadvantage for women remained, when adjusting mortality rates for confounders (age, diabetes, anterior STEMI, multivessel disease, PCI result) in a Cox regression model (table, upper part). This could be confirmed in a subgroup multivariate analysis excluding patients with no CP or not undergoing emergency PCI (table, lower part). Conclusions In STEMI-patients younger 55 years women showed a more than 60% higher short- and long-term-mortality compared to their male peers. This disadvantage, at least with our data, cannot be sufficiently explained by higher rates of delayed STEMI-presentations or absence of typical chest pain. Further studies are needed to identify possible causes for this higher vulnerability of young women to acute myocardial infarctions.Table:Mortality in Women vs. men<55 yrs

cardiac & cardiovascular systems
Sex-specific syncope characteristics in the early diagnosis of cardiac syncope

E Kaplan,J Du Fay De Lavallaz,T Zimmermann,P Lopez-Ayala,I Strebel,P Badertscher,T Nestelberger,O Miro,M Christ,L Cullen,M Than,F J Martin-Sanchez,R Manka,T Breidthardt,C Mueller

DOI: https://doi.org/10.1093/eurheartj/ehae666.637

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background The Lancet women and cardiovascular disease commission requested evaluating sex-specific approaches in the diagnosis and management of acute cardiovascular disease. Purpose We aimed to explore 1) the utility of sex-specific syncope characteristics in the early diagnosis of cardiac syncope 2) sex-related differences in the management and outcomes of patients with a cardiac syncope. Methods Thirty-one syncope characteristics were prospectively assessed in women and men presenting with syncope to the emergency department (ED) in an international multicenter study. The final diagnosis of cardiac syncope was centrally adjudicated by two independent cardiologists. Sex-specific differences in the prevalence of syncope characteristics and their positive likelihood ratio (pLR) for cardiac syncope were the primary diagnostic endpoints. Sex-specific differences in hospital admission, diagnostic procedures performed in patients with a cardiac syncope and adverse events in patients directly discharged from the ED during one-year follow-up were secondary endpoints. Results Among 2661 patients (median age 71 years, 1099 women and 1562 men), 14.6% of women and 18.2% of men (p=0.02) were adjudicated to have a cardiac syncope. Eleven syncope characteristics showed diagnostic utility (statistically significant pLRs) in assessing cardiac syncope in the overall population. However, none of the syncope characteristics demonstrated significant sex interaction. Women adjudicated as having a cardiac syncope were as likely to be hospitalized as men (OR 1.12; 95% CI: 0.61-2.08, p=0.7) and to receive telemetry (40% vs 41%, p=0.9), ergometry (3.1% vs 6.3%, p=0.4), a holter (21% vs 17%, p=0.3), a loop recorder (0.6% vs 3.9%, p=0.06) and an echocardiogram (69% vs 65%, p=0.4). Among the 591 women and 796 men directly discharged from the ED, 18 women (3%) and 36 men (5%) were finally adjudicated as cardiac syncope. Noteworthy, within this cardiac syncope subgroup, 28% of women experienced major adverse cardiac events (MACE) during the 365-day follow-up period, in comparison to 67% men (OR 0.20; 95% CI: 0.06-0.68, p=0.011, Figure). Conclusion Syncope characteristics contributed to the early diagnosis of cardiac syncope, however, none had a significant sex interaction. Women with a cardiac syncope had a similar likelihood of being hospitalized and receiving diagnostic testing. Compard to men, women had a significantly decreased risk of MACE when not hospitalized after a cardiac syncope.Kaplan-Meier curves for 1 year MACE

cardiac & cardiovascular systems
Sex Differences in Skeletal Muscle Pathology in Patients With Heart Failure and Reduced Ejection Fraction

Nathanael Wood,Annabel Critchlow,Chew W. Cheng,Sam Straw,Paul W. Hendrickse,Marcelo G. Pereira,Stephen B. Wheatcroft,Stuart Egginton,Klaus K. Witte,Lee D. Roberts,T. Scott Bowen

DOI: https://doi.org/10.1161/circheartfailure.123.011471

2024-10-10

Circulation Heart Failure

Abstract:Circulation: Heart Failure, Ahead of Print. BACKGROUND:Women with heart failure and reduced ejection fraction (HFrEF) have greater symptoms and a lower quality of life compared with men; however, the role of noncardiac mechanisms remains poorly resolved. We hypothesized that differences in skeletal muscle pathology between men and women with HFrEF may explain clinical heterogeneity.METHODS:Muscle biopsies from both men (n=22) and women (n=16) with moderate HFrEF (New York Heart Association classes I–III) and age- and sex-matched controls (n=18 and n=16, respectively) underwent transcriptomics (RNA-sequencing), myofiber structural imaging (histology), and molecular signaling analysis (gene/protein expression), with serum inflammatory profiles analyzed (enzyme-linked immunosorbent assay). Two-way ANOVA was conducted (interaction sex and condition).RESULTS:RNA-sequencing identified 5629 differentially expressed genes between men and women with HFrEF, with upregulated terms for catabolism and downregulated terms for mitochondria in men. mRNA expression confirmed an effect of sex (P<0.05) on proatrophic genes related to ubiquitin proteasome, autophagy, and myostatin systems (higher in all men versus all women), whereas proanabolicIGF1expression was higher (P<0.05) in women with HFrEF only. Structurally, women compared with men with HFrEF showed a pro-oxidative phenotype, with smaller but higher numbers of type I fibers, alongside higher muscle capillarity (Pinteraction<0.05) and higher type I fiber areal density (Pinteraction<0.05). Differences in gene/protein expression of regulators of muscle phenotype were detected between sexes, includingHIF1α,ESR1,VEGF(vascular endothelial growth factor), and PGC1α expression (P<0.05), and for upstream circulating factors, including VEGF, IL (interleukin)-6, and IL-8 (P<0.05).CONCLUSIONS:Sex differences in muscle pathology in HFrEF exist, with men showing greater abnormalities compared with women related to the transcriptome, fiber phenotype, capillarity, and circulating factors. These preliminary data question whether muscle pathology is a primary mechanism contributing to greater symptoms in women with HFrEF and highlight the need for further investigation.

cardiac & cardiovascular systems
Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey

Julia Mascherbauer,Andreas Kammerlander,Christian Nitsche,Jeroen Bax,Victoria Delgado,Arturo Evangelista,Cecile Laroche,Aldo Pietro Maggioni,Julien Magne,Alec Vahanian,Bernard Iung

DOI: https://doi.org/10.1093/eurheartj/ehae523

2024-10-05

Abstract:Background and aims: To assess sex differences in disease characteristics and treatment of patients with severe native valvular heart disease (VHD) included in the VHD II EURObservational Research Programme. Methods: A total of 5219 patients were enrolled in 208 European and North African centres and followed for 6 months [41.2% aortic stenosis (AS), 5.3% aortic regurgitation (AR), 4.5% mitral stenosis (MS), 21.3% mitral regurgitation (MR), 2.7% isolated right-sided VHD, 24.9% multiple left-sided VHD]. Indications for intervention were considered concordant if corresponding to class I recommendations specified in the 2012 ESC or 2014 AHA/ACC VHD guidelines. Results: Overall, women were older, more symptomatic, and presented with a higher EuroSCORE II. Bicuspid aortic valve and AR were more prevalent among men while mitral disease, concomitant tricuspid regurgitation (TR), and AS above age 65 were more prevalent among women. On multivariable regression analysis, concordance with recommended treatment was significantly poorer in women with MS and primary MR (both P < .001). Age, patient refusal, and decline of symptoms after conservative treatment were reported significantly more often as reasons to withhold the intervention in females. Concomitant tricuspid intervention was performed at a similar rate in both sexes although prevalence of significant TR was significantly higher in women. In-hospital and 6-month survival did not differ between sexes. Conclusions: (i) Valvular heart disease subtype varied between sexes; (ii) concordance with recommended intervention for MS and primary MR was significantly lower for women; and (iii) survival of men and women was similar at 6 months.
Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling

Anvesha Singh,Daniel C S Chan,John P Greenwood,Dana K Dawson,Piotr Sonecki,Kai Hogrefe,Damian J Kelly,Vijay Dhakshinamurthy,Chim C Lang,Jeffery P Khoo,David Sprigings,Richard P Steeds,Ruiqi Zhang,Ian Ford,Michael Jerosch-Herold,Jing Yang,Zhuyin Li,Leong L Ng,Gerry P McCann

DOI: https://doi.org/10.1016/j.jcmg.2017.09.019

Abstract:Objectives: The aim of this study was to establish sex differences in remodeling and outcome in aortic stenosis (AS) and their associations with biomarkers of myocardial fibrosis. Background: The remodeling response and timing of symptoms is highly variable in AS, and sex plays an important role. Methods: A total of 174 patients (133 men, mean age 66.2 ± 13.3 years) with asymptomatic moderate to severe AS underwent comprehensive stress cardiac magnetic resonance imaging, transthoracic echocardiography, and biomarker analysis (matrix metalloproteinase [MMP]-2, -3, -7, -8, and -9; tissue inhibitor matrix metalloproteinases-1 and -4; syndecan-1 and -4; and N-terminal pro-B-type natriuretic peptide), and were followed up at 6-month intervals. A primary endpoint was a composite of typical AS symptoms necessitating referral for aortic valve replacement, cardiovascular death, or major adverse cardiovascular events. Results: For a similar severity of AS, male patients demonstrated higher indexed left ventricular (LV) volumes and mass, more concentric remodeling (higher LV mass/volume), a trend to more late gadolinium enhancement (present in 51.1% men vs. 34.1% women; p = 0.057), and higher extracellular volume index than female patients (13.27 [interquartile range (IQR): 11.5 to 17.0] vs. 11.53 [IQR: 10.5 to 13.5] ml/m2, p = 0.017), with worse systolic and diastolic function and higher MMP-3 and syndecan-4 levels, whereas female patients had higher septal E/e'. Male sex was independently associated with indexed LV mass (β = 13.32 [IQR: 9.59 to 17.05]; p < 0.001). During median follow-up of 374 (IQR: 351 to 498) days, a primary outcome, driven by spontaneous symptom onset, occurred in 21.8% of male and 43.9% of female patients (relative risk: 0.50 [95% confidence interval: 0.31 to 0.80]; p = 0.004). Measures of AS severity were associated with the primary outcome in both sexes, whereas N-terminal pro-B-type natriuretic peptide, MMP-3, and mass/volume were only associated in men. Conclusions: In AS, women tolerate pressure overload with less concentric remodeling and myocardial fibrosis but are more likely to develop symptoms. This may be related to higher wall stress and filling pressures in women.
Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study

Nicholas Weight,Saadiq Moledina,Evangelos Kontopantelis,Harriette Van Spall,Mohammed Dafaalla,Alaide Chieffo,Mario Iannaccone,Denis Chen,Muhammad Rashid,Josepa Mauri-Ferre,Jacqueline E Tamis-Holland,Mamas A Mamas

DOI: https://doi.org/10.1093/ehjqcco/qcae011

2024-02-06

European Heart Journal - Quality of Care and Clinical Outcomes

Abstract:Abstract Background Contemporary studies demonstrate that non-ST-segment elevation myocardial infarction (NSTEMI) processes of care vary according to sex. Little is known regarding variation in practice between geographical areas and centres. Methods We identified 305 014 NSTEMI admissions in the United Kingdom (UK) Myocardial Ischaemia National Audit Project (MINAP), 2010–17, including female sex (110 209). Hierarchical, multivariate logistic regression models were fitted, assessing for differences in primary outcomes according to sex. Risk-standardized mortality rates (RSMR) were calculated for individual hospitals to illustrate the correlation with variables of interest. ‘Heat maps’ were plotted to show regional and sex-based variation in the opportunity-based quality indicator score (surrogate for optimal processes of care). Results Women presented older (77 years vs. 69 years, P < 0.001) and were more often Caucasian (93% vs. 91%, P < 0.001). Women were less frequently managed with an invasive coronary angiogram (58% vs. 75%, P < 0.001) or percutaneous coronary intervention (35% vs. 49%, P < 0.001). In our hospital-clustered analysis, we show a positive correlation between the RSMR and the increasing proportion of women treated for NSTEMI (R2 = 0.17, P < 0.001). There was a clear negative correlation between the proportion of women who had an optimum OBQI score during their admission and RSMR (R2 = 0.22, P < 0.001), with a weaker correlation in men (R2 = 0.08, P < 0.001). Heat maps according to the Clinical Commissioning Group (CCG) demonstrate significant regional variation in the OBQI score, with women receiving poorer quality care throughout the UK. Conclusion There was a significant variation in the management of patients with NSTEMI according to sex, with widespread geographical variation. Structural changes are required to enable improved care for women.

cardiac & cardiovascular systems
Age- and sex-based differences in patients with acute pericarditis

George Lazaros,Alexios S Antonopoulos,Emilia Lazarou,Charalambos Vlachopoulos,Georgia Vogiatzi,Dimitrios Vassilopoulos,Dimitris Tousoulis

DOI: https://doi.org/10.1111/eci.13392

Abstract:Background: Acute pericarditis has a wide spectrum of clinical presentations largely depending on underlying aetiologies. We assessed the role of age and sex in the clinical features and outcome of acute pericarditis. Materials and methods: A total of 240 consecutive patients hospitalized with a first episode of acute pericarditis were included. At baseline demographics, clinical features, laboratory and imaging findings and medical therapy were recorded. Patients were followed up for at least 18 months for complications. Data comparisons were performed according to sex and age (≤60 or >60 years). Results: The male/female ratio was 1.42, and 56% of patients were >60 years. Younger patients depicted more often chest pain (P = .001), fever and rubs (P < .001 for both), ST elevation and PR depression (P = .032 and .009, respectively), higher CRP values (P = .009) and less often dyspnoea (P = .046) and pericardial effusion (P = .036). Moreover, they received less often glucocorticoids (P < .001) and depicted less atrial fibrillation (P = .003) and a higher rate of recurrent pericarditis (P = .013). After multivariate adjustment for confounders, age >60 years remained an independent predictor for a lower risk of recurrent pericarditis (hazard ratio 0.60, 95% CI: 0.39-0.96, P = .033). Regarding sex, females were older (P = .007), showed less often ST elevation and PR depression (P < .001 and .002, respectively) and had a higher baseline heart rate (P = .02). Sex was not associated with recurrent pericarditis risk. Conclusions: Patients with acute pericarditis have distinct presenting clinical, biochemical and prognostic features according to age and sex. Awareness of such differences is important for clinical decision-making.

[Multiplicity and significance of autoantibodies in the megaloblastic anemias].

Sex and gender differences in myocarditis and dilated cardiomyopathy: An update

Sex-based differences in the phenotypic expression and prognosis of idiopathic non-ischaemic cardiomyopathy: a cardiovascular magnetic resonance study

Predicting Major League Baseball Championship Winners through Data Mining

Abstract TMP65: Sex Differences in Outcomes of Acute Myocardial Injury After Stroke

Sex-related Differences in Patients with Infective Endocarditis Requiring Cardiac Surgery: Insights from the CAMPAIGN Study Group

Sex differences in cardiac structure and function following acute myocardial infarction: Insights from the PARADISE‐MI echocardiographic substudy

Sex differences in outcomes of patients with cardiogenic shock due to acute myocardial infarction: a systematic review and epidemiological meta-analysis

Sex Differences in the Incidence and Risk Factors of Myocardial Injury in COVID-19 Patients: A Retrospective Cohort Study

Sex differences in acute myocardial infarction - Preliminary results from an umbrella review

Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative

Prospective comparison of temporal myocardial function in men vs women after anterior ST-elevation myocardial infarction

Specificities of Myocardial Infarction and Heart Failure in Women

Post-COVID-19 illness and associations with sex and gender

Comparison of clinical symptoms and prognosis of non-post-menopausal women to age matched men admitted with ST-elevation myocardial infarctions

Sex-specific syncope characteristics in the early diagnosis of cardiac syncope

Sex Differences in Skeletal Muscle Pathology in Patients With Heart Failure and Reduced Ejection Fraction

Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey

Symptom Onset in Aortic Stenosis: Relation to Sex Differences in Left Ventricular Remodeling

Sex-based analysis of NSTEMI processes of care and outcomes by hospital: a nationwide cohort study

Age- and sex-based differences in patients with acute pericarditis